These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22826606)

  • 1. Changing the tumor microenvironment: new strategies for immunotherapy.
    Berraondo P; Umansky V; Melero I
    Cancer Res; 2012 Oct; 72(20):5159-64. PubMed ID: 22826606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic modulation of lymphocyte function by stromal cell network: advance in therapeutic targeting of cancer.
    Görgün G; Anderson KC
    Immunotherapy; 2011 Oct; 3(10):1253-64. PubMed ID: 21995575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy.
    Barrett R; Puré E
    Curr Opin Immunol; 2020 Jun; 64():80-87. PubMed ID: 32402828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?
    Puré E; Lo A
    Cancer Immunol Res; 2016 Apr; 4(4):269-78. PubMed ID: 27036971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy: target the stroma to hit the tumor.
    Kammertoens T; Schüler T; Blankenstein T
    Trends Mol Med; 2005 May; 11(5):225-31. PubMed ID: 15882610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor microenvironment: part 1.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1367-84. PubMed ID: 22053887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
    Chouaib S; Noman MZ; Kosmatopoulos K; Curran MA
    Oncogene; 2017 Jan; 36(4):439-445. PubMed ID: 27345407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pancreatic Cancer Microenvironment.
    Dougan SK
    Cancer J; 2017; 23(6):321-325. PubMed ID: 29189327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the tumor microenvironment for cancer therapy.
    Sounni NE; Noel A
    Clin Chem; 2013 Jan; 59(1):85-93. PubMed ID: 23193058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells.
    Poggi A; Musso A; Dapino I; Zocchi MR
    Immunol Lett; 2014; 159(1-2):55-72. PubMed ID: 24657523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment and the role of mesenchymal stromal cells.
    Kucerova L; Skolekova S
    Neoplasma; 2013; 60(1):1-10. PubMed ID: 23067210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving homing in T cell therapy.
    Vignali D; Kallikourdis M
    Cytokine Growth Factor Rev; 2017 Aug; 36():107-116. PubMed ID: 28690108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming tumor-mediated immunosuppression.
    Schlößer HA; Theurich S; Shimabukuro-Vornhagen A; Holtick U; Stippel DL; von Bergwelt-Baildon M
    Immunotherapy; 2014; 6(9):973-88. PubMed ID: 25341119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type.
    Fabre J; Giustiniani J; Garbar C; Antonicelli F; Merrouche Y; Bensussan A; Bagot M; Al-Dacak R
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coinhibitory Pathways in Immunotherapy for Cancer.
    Baumeister SH; Freeman GJ; Dranoff G; Sharpe AH
    Annu Rev Immunol; 2016 May; 34():539-73. PubMed ID: 26927206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the tumor and its associated stroma: One and one can make three in adoptive T cell therapy of solid tumors.
    Mondino A; Vella G; Icardi L
    Cytokine Growth Factor Rev; 2017 Aug; 36():57-65. PubMed ID: 28629762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumors.
    Liu A; Hu P; Khawli LA; Epstein AL
    J Immunother; 2006; 29(4):425-35. PubMed ID: 16799338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Insights into the Role of Autophagy in Tumor Immune Microenvironment.
    Li CJ; Liao WT; Wu MY; Chu PY
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.
    Anari F; Ramamurthy C; Zibelman M
    Future Oncol; 2018 Jun; 14(14):1409-1421. PubMed ID: 29848096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.